skip to main content
Idioma:

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2

Hippisley-Cox, Julia ; Coupland, Carol ; Vinogradova, Yana ; Robson, John ; Minhas, Rubin ; Sheikh, Aziz ; Brindle, Peter

BMJ, 2008-06, Vol.336 (7659), p.1475-1482 [Periódico revisado por pares]

London: British Medical Journal Publishing Group

Texto completo disponível

Citações Citado por
  • Título:
    Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
  • Autor: Hippisley-Cox, Julia ; Coupland, Carol ; Vinogradova, Yana ; Robson, John ; Minhas, Rubin ; Sheikh, Aziz ; Brindle, Peter
  • Assuntos: Adult ; Age Distribution ; Aged ; Algorithms ; Biological and medical sciences ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - mortality ; Datasets ; Disease models ; Disease risk ; England - epidemiology ; Epidemiologic Studies ; Ethnic groups ; Ethnicity ; Female ; General aspects ; General practice ; Humans ; Male ; Medical research ; Medical sciences ; Men ; Middle Aged ; Minority & ethnic groups ; Predisposing factors ; Primary health care ; Prognosis ; Risk assessment ; Sex Distribution ; Wales - epidemiology
  • É parte de: BMJ, 2008-06, Vol.336 (7659), p.1475-1482
  • Notas: PMID:18573856
    local:bmj;336/7659/1475
    istex:44946975A79FEE17FBDE999A0E924B47369D017F
    href:bmj-336-1475.pdf
    ark:/67375/NVC-88VT55S6-1
    ArticleID:hipj576058
    ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-3
    content type line 23
    ObjectType-Undefined-2
  • Descrição: Objective To develop and validate version two of the QRISK cardiovascular disease risk algorithm (QRISK2) to provide accurate estimates of cardiovascular risk in patients from different ethnic groups in England and Wales and to compare its performance with the modified version of Framingham score recommended by the National Institute for Health and Clinical Excellence (NICE).Design Prospective open cohort study with routinely collected data from general practice, 1 January 1993 to 31 March 2008.Setting 531 practices in England and Wales contributing to the national QRESEARCH database.Participants 2.3 million patients aged 35-74 (over 16 million person years) with 140 000 cardiovascular events. Overall population (derivation and validation cohorts) comprised 2.22 million people who were white or whose ethnic group was not recorded, 22 013 south Asian, 11 595 black African, 10 402 black Caribbean, and 19 792 from Chinese or other Asian or other ethnic groups.Main outcome measures First (incident) diagnosis of cardiovascular disease (coronary heart disease, stroke, and transient ischaemic attack) recorded in general practice records or linked Office for National Statistics death certificates. Risk factors included self assigned ethnicity, age, sex, smoking status, systolic blood pressure, ratio of total serum cholesterol:high density lipoprotein cholesterol, body mass index, family history of coronary heart disease in first degree relative under 60 years, Townsend deprivation score, treated hypertension, type 2 diabetes, renal disease, atrial fibrillation, and rheumatoid arthritis.Results The validation statistics indicated that QRISK2 had improved discrimination and calibration compared with the modified Framingham score. The QRISK2 algorithm explained 43% of the variation in women and 38% in men compared with 39% and 35%, respectively, by the modified Framingham score. Of the 112 156 patients classified as high risk (that is, ≥20% risk over 10 years) by the modified Framingham score, 46 094 (41.1%) would be reclassified at low risk with QRISK2. The 10 year observed risk among these reclassified patients was 16.6% (95% confidence interval 16.1% to 17.0%)—that is, below the 20% treatment threshold. Of the 78 024 patients classified at high risk on QRISK2, 11 962 (15.3%) would be reclassified at low risk by the modified Framingham score. The 10 year observed risk among these patients was 23.3% (22.2% to 24.4%)—that is, above the 20% threshold. In the validation cohort, the annual incidence rate of cardiovascular events among those with a QRISK2 score of ≥20% was 30.6 per 1000 person years (29.8 to 31.5) for women and 32.5 per 1000 person years (31.9 to 33.1) for men. The corresponding figures for the modified Framingham equation were 25.7 per 1000 person years (25.0 to 26.3) for women and 26.4 (26.0 to 26.8) for men). At the 20% threshold, the population identified by QRISK2 was at higher risk of a CV event than the population identified by the Framingham score.Conclusions Incorporating ethnicity, deprivation, and other clinical conditions into the QRISK2 algorithm for risk of cardiovascular disease improves the accuracy of identification of those at high risk in a nationally representative population. At the 20% threshold, QRISK2 is likely to be a more efficient and equitable tool for treatment decisions for the primary prevention of cardiovascular disease. As the validation was performed in a similar population to the population from which the algorithm was derived, it potentially has a “home advantage.” Further validation in other populations is therefore advised.
  • Editor: London: British Medical Journal Publishing Group
  • Idioma: Inglês
Links
Voltar para lista de resultados
Ir para página anteriorAnterior Resultado  10 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.